Ketamine Therapy Referral Guidelines for Primary Care Physicians

As ketamine therapy becomes increasingly recognized for treatment-resistant depression and other mental health conditions, primary care physicians play a crucial role in identifying appropriate candidates and facilitating referrals. This guide provides evidence-based criteria for effective ketamine therapy referrals.

Clinical Indications for Ketamine Therapy Referral

Primary Indications

Treatment-Resistant Depression (TRD):

• Failure of 2+ adequate antidepressant trials (6-8 weeks each at therapeutic doses)
• PHQ-9 scores ≥15 despite optimal medical management
• Functional impairment affecting work, relationships, or daily activities
• Patient preference for alternative to continued medication trials

Major Depressive Disorder with Suicidal Ideation:

• Active suicidal ideation requiring rapid intervention
• Recent suicide attempts with ongoing depression
• Emergency department presentations for mental health crisis
• Inpatient discharge planning requiring intensive outpatient support

Secondary Indications

Anxiety Disorders:

• Generalized anxiety disorder unresponsive to first-line treatments
• Panic disorder with agoraphobia limiting function
• Social anxiety disorder affecting professional/personal life
• PTSD with inadequate response to trauma-focused therapies

Chronic Pain Syndromes:

• Fibromyalgia with comorbid depression
• Complex regional pain syndrome (CRPS)
• Neuropathic pain syndromes
• Chronic pain with central sensitization features

Conclusion

Effective ketamine therapy referrals require thorough assessment, appropriate patient selection, and robust care coordination. By following evidence-based guidelines and maintaining collaborative relationships with ketamine providers, primary care physicians can significantly improve outcomes for patients with treatment-resistant mental health conditions.